one hundred twenty-one patients with diffuse large-cell lymphoma treated with m- or m-bacod ( methotrexate , bleomycin , doxorubicin , cyclophosphamide , vincristine , and dexamethasone ) were evaluated for pretreatment characteristics predictive for response and survival .
C0083304
m-bacod
C0042679
vincristine